Early Stroke and Mortality After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
暂无分享,去创建一个
S. Markowitz | G. Thomas | CHRISTOPHER F. Liu | James E. Ip | B. Lerman | C. Sciria | Jim W. Cheung | S. Wong | L. Kim | G. Bergman | E. Kogan
[1] S. Mandava,et al. TCT-92 Comparison of Procedural, Safety, and Efficacy Outcomes of Watchman FLX Versus Watchman 2.5 , 2021, Journal of the American College of Cardiology.
[2] Laura Martin,et al. PD32-09 SOCIOECONOMIC PREDICTORS OF RECEIVING A VAGINAL HYSTERECTOMY COMPARED TO OPEN AND LAPAROSCOPIC/ROBOTIC APPROACHES FOR TREATMENT OF APICAL PROLAPSE: AN ANALYSIS OF OVER 38,000 WOMEN IN THE HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) , 2021 .
[3] T. Kuno,et al. Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion , 2021, Heart.
[4] Frederick T. Han,et al. Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry. , 2021, JAMA cardiology.
[5] V. Reddy,et al. Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device , 2021, Circulation.
[6] Anas M. Saad,et al. Association of Hospital Procedural Volume With Outcomes of Percutaneous Left Atrial Appendage Occlusion. , 2021, JACC. Cardiovascular interventions.
[7] M. Price,et al. The NCDR Left Atrial Appendage Occlusion Registry. , 2020, Journal of the American College of Cardiology.
[8] E. Heist,et al. Incidence and Causes of In-hospital Outcomes and 30-day Readmissions After Percutaneous Left Atrial Appendage Closure: A United States Nationwide Retrospective Cohort Study Using Claims Data. , 2020, Heart rhythm.
[9] D. Delurgio,et al. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. , 2019, Journal of the American College of Cardiology.
[10] S. Markowitz,et al. Risk of Mortality Following Catheter Ablation of Atrial Fibrillation. , 2019, Journal of the American College of Cardiology.
[11] H. Kamel,et al. Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. , 2019, European heart journal.
[12] R. Swaminathan,et al. Thirty‐Day Readmission Rates, Timing, Causes, and Costs after ST‐Segment–Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010–2014 , 2018, Journal of the American Heart Association.
[13] Saibal Kar,et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.
[14] S. Kische,et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.
[15] R. Virmani,et al. Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. , 2010, JACC. Cardiovascular interventions.
[16] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.
[17] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. , 2007, Annals of internal medicine.
[18] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.
[19] Valentin Fuster,et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. , 2003, Circulation.
[20] J. Odell,et al. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.
[21] N. Ammash,et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.
[22] W. Daniel,et al. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. , 1994, Journal of the American College of Cardiology.